High Serum IGFBP-2 in Acute Lymphoblastic Leukemia may be an Indication for Increased Risk of Relapse

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-642-71960-8_49
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-Like Growth Factors and Their Specific Binding Proteins in Leukemia (ALL) and Non-Hodgkin Lymphoma

  1997cited by this paper
• Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults.

  1995cited by this paper
• Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells.

  1995cited by this paper
• Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct.

  1995cited by this paper
• Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.

  1994cited by this paper
• Levels of insulin-like growth factor-binding protein-2 and insulin-like growth factor-II in maternal serum, amniotic fluid and extraembryonic coelomic fluid at 9-20 weeks of pregnancy.

  1994cited by this paper
• The IGF axis in the prostate.

  1994cited by this paper
• Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour.

  1993cited by this paper
• Clinical studies of IGFBP-2 by radioimmunoassay.

  1993cited by this paper
• Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.

  1993cited by this paper
• The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes.

  1993cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.

  1992cited by this paper
• Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group.

  1992cited by this paper
• Characterisation of insulin-like growth factor I receptors of human acute lymphoblastic leukaemia (ALL) cell lines and primary ALL cells.

  1992cited by this paper
• Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts.

  1991cited by this paper
• Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4.

  1991cited by this paper
• Insulinlike growth factors in human malignancy.

  1991cited by this paper
• A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.

  1990cited by this paper
• Insulin-like growth factors and their binding proteins.

  1990cited by this paper
• An altered IGF-I receptor is present in human leukemic cells.

  1990cited by this paper
• Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I.

  1989cited by this paper
• A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.

  1988cited by this paper
• Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis.

  1987cited by this paper

• Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice

  2015cites this paper
• IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

  2001cites this paper
• Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.

  1998cites this paper